|
| 37815489 | Plasma Microbial Cell-Free DNA Sequencing in Immunocompromised Patients With Pneumonia: A Prospective Observational Study. | Clin Infect Dis | 2024 |
| 38001039 | Use of Transcriptional Signatures to Differentiate Pathogen-Specific and Treatment-Specific Host Responses in Patients With Bacterial Bloodstream Infections. | J Infect Dis | 2024 |
| 37740559 | Moving Beyond Mortality: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia. | Clin Infect Dis | 2024 |
| 37738153 | Clinical Outcomes and Bacterial Characteristics of Carbapenem-resistant Acinetobacter baumannii Among Patients From Different Global Regions. | Clin Infect Dis | 2024 |
| 37975818 | Reply to Author. | Clin Infect Dis | 2024 |
| 36262037 | Clinically Adjudicated Reference Standards for Evaluation of Infectious Diseases Diagnostics. | Clin Infect Dis | 2023 |
| 37754204 | Ceftobiprole for Treatment of Complicated <i>Staphylococcus aureus</i> Bacteremia. | N Engl J Med | 2023 |
| 37556556 | Preclinical safety and efficacy characterization of an LpxC inhibitor against Gram-negative pathogens. | Sci Transl Med | 2023 |
| 37851461 | Lead Extraction and Mortality Among Patients With Cardiac Implanted Electronic Device Infection. | JAMA Cardiol | 2023 |
| 37747828 | Risk Factors and Outcomes of Hematogenous Vertebral Osteomyelitis in Patients With Staphylococcus aureus Bacteremia. | Clin Infect Dis | 2023 |
| 38060808 | Reply to Robertson: True Staphylococcus aureus bacteremia. | Clin Infect Dis | 2023 |
| 37843121 | The Antibacterial Resistance Leadership Group: Scientific Advancements and Future Directions. | Clin Infect Dis | 2023 |
| 37843122 | The Future Ain't What It Used to Be⿦Out With the Old⿦In With the Better: Antibacterial Resistance Leadership Group Innovations. | Clin Infect Dis | 2023 |
| 37843120 | Under the Hood: The Scientific Leadership, Clinical Operations, Statistical and Data Management, and Laboratory Centers of the Antibacterial Resistance Leadership Group. | Clin Infect Dis | 2023 |
| 37843118 | Priorities and Progress in Gram-negative Bacterial Infection Research by the Antibacterial Resistance Leadership Group. | Clin Infect Dis | 2023 |
| 37790275 | Inflammasome-mediated glucose limitation induces antibiotic tolerance in <i>Staphylococcus aureus</i>. | iScience | 2023 |
| 37698412 | Daily fosfomycin versus levofloxacin for complicated urinary tract infections. | mBio | 2023 |
| 37541582 | Positron emission tomography-computed tomography in patients with Staphylococcus aureus bacteraemia: worth the wait? | Clin Microbiol Infect | 2023 |
| 37974651 | Mapping disease regulatory circuits at cell-type resolution from single-cell multiomics data. | Nat Comput Sci | 2023 |
| 35684984 | Microbial Cell-Free DNA Identifies the Causative Pathogen in Infective Endocarditis and Remains Detectable Longer Than Conventional Blood Culture in Patients with Prior Antibiotic Therapy. | Clin Infect Dis | 2023 |
| 37425926 | Human Immune Cell Epigenomic Signatures in Response to Infectious Diseases and Chemical Exposures. | bioRxiv | 2023 |
| 37321394 | The association of female sex with management and mortality in patients with Staphylococcus aureus bacteraemia. | Clin Microbiol Infect | 2023 |
| 37154071 | International Epidemiology of Carbapenemase-Producing Escherichia coli. | Clin Infect Dis | 2023 |
| 36978320 | Persistent Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia: Host, Pathogen, and Treatment. | Antibiotics (Basel) | 2023 |
| 37379418 | Reply to Yamamoto, Lindberg et al, Xie and Tong, and Sunnerhagen et al. | Clin Infect Dis | 2023 |
| 37310693 | Global Differences in the Management of Staphylococcus aureus Bacteremia: No International Standard of Care. | Clin Infect Dis | 2023 |
| 37040826 | Which trial do we need? Next-generation sequencing to individualize therapy in Staphylococcus aureus bacteraemia. | Clin Microbiol Infect | 2023 |
| 37338371 | Escherichia coli ST131 Associated with Increased Mortality in Bloodstream Infections from Urinary Tract Source. | J Clin Microbiol | 2023 |
| 37073571 | Exploration of a Potential Desirability of Outcome Ranking Endpoint for Complicated Intra-Abdominal Infections Using 9 Registrational Trials for Antibacterial Drugs. | Clin Infect Dis | 2023 |
| 37138445 | The 2023 Duke-International Society for Cardiovascular Infectious Diseases Criteria for Infective Endocarditis: Updating the Modified Duke Criteria. | Clin Infect Dis | 2023 |
| 37229554 | Candidemia in thoracic solid organ transplant recipients: Characteristics and outcomes relative to matched uninfected and bacteremic thoracic organ transplant recipients. | Clin Transplant | 2023 |
| 36881936 | Reply to Author. | Clin Infect Dis | 2023 |
| 36774938 | Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study. | Lancet Microbe | 2023 |
| 36603774 | All Staphylococcus aureus bacteraemia-inducing strains can cause infective endocarditis: Results of GWAS and experimental animal studies. | J Infect | 2023 |
| 36602380 | MRSA Isolates from Patients with Persistent Bacteremia Generate Nonstable Small Colony Variants <i>In Vitro</i> within Macrophages and Endothelial Cells during Prolonged Vancomycin Exposure. | Infect Immun | 2023 |
| 36373405 | Black and White Patients With Staphylococcus aureus Bacteremia Have Similar Outcomes but Different Risk Factors. | Clin Infect Dis | 2023 |
| 36370898 | Redefining Staphylococcus aureus bacteremia: A structured approach guiding diagnostic and therapeutic management. | J Infect | 2023 |
| 36173830 | Transmission of Carbapenem-Resistant Klebsiella pneumoniae in US Hospitals. | Clin Infect Dis | 2023 |
| 35929656 | Clinical and Molecular Analyses of Recurrent Gram-Negative Bloodstream Infections. | Clin Infect Dis | 2023 |
| 36031403 | Improving Traditional Registrational Trial End Points: Development and Application of a Desirability of Outcome Ranking End Point for Complicated Urinary Tract Infection Clinical Trials. | Clin Infect Dis | 2023 |
| 34303771 | Staphylococcus aureus Bacteremia Among Patients Receiving Maintenance Hemodialysis: Trends in Clinical Characteristics and Outcomes. | Am J Kidney Dis | 2022 |
| 35615299 | A Desirability of Outcome Ranking Analysis of a Randomized Clinical Trial Comparing Seven Versus Fourteen Days of Antibiotics for Uncomplicated Gram-Negative Bloodstream Infection. | Open Forum Infect Dis | 2022 |
| 35836748 | PROPHETIC EU: Prospective Identification of Pneumonia in Hospitalized Patients in the Intensive Care Unit in European and United States Cohorts. | Open Forum Infect Dis | 2022 |
| 35578360 | Dalbavancin as an option for treatment of S. aureus bacteremia (DOTS): study protocol for a phase 2b, multicenter, randomized, open-label clinical trial. | Trials | 2022 |
| 35639909 | Heterogeneity in Staphylococcus aureus Bacteraemia Clinical Trials Complicates Interpretation of Findings. | J Infect Dis | 2022 |
| 35535790 | Persistent Methicilin-Resistant Staphylococcus aureus Bacteremia: Resetting the Clock for Optimal Management. | Clin Infect Dis | 2022 |
| 35357213 | Accessory Genomes Drive Independent Spread of Carbapenem-Resistant Klebsiella pneumoniae Clonal Groups 258 and 307 in Houston, TX. | mBio | 2022 |
| 36411527 | Gram-negative bacteremia in solid organ transplant recipients: Clinical characteristics and outcomes as compared to immunocompetent non-transplant recipients. | Transpl Infect Dis | 2022 |
| 36136334 | Association of Follow-up Blood Cultures With Mortality in Patients With Gram-Negative Bloodstream Infections: A Systematic Review and Meta-analysis. | JAMA Netw Open | 2022 |
| 35863018 | Carbapenemase-Encoding Gene Copy Number Estimator (CCNE): a Tool for Carbapenemase Gene Copy Number Estimation. | Microbiol Spectr | 2022 |